NeOnc Technologies (NTHI) Stuns Wall Street With Breakthrough 21% Response Rate in Brain Cancer Trial
NeOnc Technologies Holdings Inc. (OTC:NTHI) is a multi–Phase 2 clinical-stage biopharmaceutical company founded to solve one of the…
Browsing Tag